These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17805040)

  • 1. Anti-D immunoglobulin-induced prolonged intravascular hemolysis and neutropenia.
    Alioglu B; Avci Z; Ozyurek E; Ozbek N
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):636-9. PubMed ID: 17805040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute renal failure after intravenous anti-D immune globulin in an adult with immune thrombocytopenic purpura.
    Chun NS; Savani B; Seder RH; Taplin ME
    Am J Hematol; 2003 Dec; 74(4):276-9. PubMed ID: 14635210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura.
    Kane I; Ragucci D; Shatat IF; Bussel J; Kalpatthi R
    Br J Haematol; 2010 Apr; 149(1):79-83. PubMed ID: 20096011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic thrombocytopenia purpura: Treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy.
    Simpson KN; Coughlin CM; Eron J; Bussel JB
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):58-64. PubMed ID: 9523750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
    Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM
    Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute immune thrombocytopenic purpura.
    Tarantino MD; Goldsmith G
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid irreversible encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura.
    Christopher K; Horkan C; Barb IT; Arbelaez C; Hodgdon TA; Yodice PC
    Am J Hematol; 2004 Nov; 77(3):299-302. PubMed ID: 15495245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children.
    Freiberg A; Mauger D
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. After eight-year-tolerance minimal i.v. anti-D infusions unleash hemolysis in a patient with immune thrombocytopenic purpura (ITP).
    Rewald MD; Francischetti MM
    Transfus Apher Sci; 2004 Apr; 30(2):105-10. PubMed ID: 15062747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.
    Tarantino MD; Young G; Bertolone SJ; Kalinyak KA; Shafer FE; Kulkarni R; Weber LC; Davis ML; Lynn H; Nugent DJ;
    J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed hemolysis after intravenous anti-D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura.
    Rubinstein PG; Chen YH
    Am J Hematol; 2008 Aug; 83(8):684-5. PubMed ID: 18508323
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the effects of and earliest response rate to anti-D treatment in children with chronic idiopathic thrombocytopenic purpura: a pilot study.
    Yetgin S; Aytaç S; Olcay L; Tunç B; Ozbek N; Aydinok Y
    Turk J Pediatr; 2010; 52(2):126-31. PubMed ID: 20560246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the mechanism for acute hemolysis occurring in some patients after intravenous anti-D therapy for immune thrombocytopenic purpura?
    Garratty G
    Transfusion; 2009 Jun; 49(6):1026-31. PubMed ID: 19638151
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous anti-D immune globulin-induced intravascular hemolysis in Epstein-Barr virus-related thrombocytopenia.
    Levendoglu-Tugal O; Jayabose S
    J Pediatr Hematol Oncol; 2001 Oct; 23(7):460-3. PubMed ID: 11878583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T
    J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single dose of anti-D immunoglobulin raises platelet count as efficiently as intravenous immunoglobulin in newly diagnosed immune thrombocytopenic purpura in Korean children.
    Son DW; Jeon IS; Yang SW; Cho SH
    J Pediatr Hematol Oncol; 2008 Aug; 30(8):598-601. PubMed ID: 18799936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins.
    Rodeghiero F; Schiavotto C; Castaman G; Vespignani M; Ruggeri M; Dini E
    Haematologica; 1992; 77(3):248-52. PubMed ID: 1330848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP).
    Tarantino MD; Bussel JB; Cines DB; McCrae KR; Gernsheimer T; Liebman HA; Wong WY; Kulkarni R; Grabowski E; McMillan R
    Blood; 2007 Jun; 109(12):5527; author reply 5528. PubMed ID: 17554071
    [No Abstract]   [Full Text] [Related]  

  • 20. Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura.
    Gaines AR
    Blood; 2005 Sep; 106(5):1532-7. PubMed ID: 15878975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.